ReviewMarine drugs2024
Valorization of the Invasive Blue Crabs (
Review in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Animal-Origin Food Waste Across Global Supply Chains: Trends, Upcycling Strategies, and Circular Economy Solutions.Foods (Basel, Switzerland) · 2026Review
- Enzymatic Valorization of Whole Blue Crab (Foods (Basel, Switzerland) · 2026Article
- TrappingAnimals : an open access journal from MDPI · 2026Article
- Chemical Characterization and Biological Activity of Astaxanthin Extracted fromInternational journal of molecular sciences · 2026Article
- Valorization of Hemp, Shrimp and Blue Crab Co-Products as Novel Culture Media Ingredients to Improve Protein Quality and Antioxidant Capacity of Cultured Meat in Cell-Based Food Applications.Foods (Basel, Switzerland) · 2026Article
- From Ecological Threat to Bioactive Resource: The Nutraceutical Components of Blue Crab (International journal of molecular sciences · 2025Article
- Valorization of Blue Crab (Animals : an open access journal from MDPI · 2025Article
- Meat Nutritional Value and Exoskeleton Valorisation ofMarine drugs · 2025Article
- Assessing heavy metal accumulation in the invasive blue crab (Callinectes sapidus): environmental and human health implications.Environmental science and pollution research international · 2025Article
- Bioactive Molecules from the Invasive Blue CrabMarine drugs · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The blue crab (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.